StemCell Therapy

Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts (D.M.K., J.K.P., J.B.W.)

Erasmus Medical Center, Rotterdam, the Netherlands, and Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts (D.V.)

Boston University, Boston, Massachusetts (R.D.)

Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California (S.G., J.P.I.)

University of Michigan, Ann Arbor, Michigan (R.H.)

Duke Clinical Research Institute, Duke University, Durham, North Carolina (B.P., M.P.)

Virginia Polytechnic Institute and State University, Blacksburg, Virginia (S.M.)

Center for Clinical Evidence Synthesis, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts (G.R.)

Schools of Medicine and Public Health, Yale University, New Haven, Connecticut (J.S.R.)

Center for Cardiovascular Health Services Research, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Tufts Clinical and Translational Science Institute, Boston, Massachusetts (H.P.S.)

Center on Aging and Health, Johns Hopkins University, Baltimore, Maryland (R.V.)

Memorial Sloan Kettering Cancer Center, New York, New York (A.V.)

Leiden University Medical Center, Leiden, the Netherlands (E.W.S.)

Disclaimer: The views, statements, and opinions presented in this work are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors, or its Methodology Committee.

Acknowledgment: The authors thank Mark Adkins, Teddy Balan, and Dan Sjoberg for excellent technical support in analyses included in the figures and supporting appendix tables. They also thank the Annals of Internal Medicine editors and reviewers, whose thoughtful feedback greatly improved this work. They thank Jennifer Lutz and Christine Lundquist for assistance with copyediting and creating exhibits.

Financial Support: Development of the PATH Statement was supported through contract SA.Tufts.PARC.OSCO.2018.01.25 from the PCORI Predictive Analytics Resource Center. This work was also informed by a 2018 conference (Evidence and the Individual Patient: Understanding Heterogeneous Treatment Effects for Patient-Centered Care) convened by the National Academy of Medicine and funded through a PCORI Eugene Washington Engagement Award (1900-TMC).

Disclosures: Dr. Kent reports grants from PCORI during the conduct of the study. Dr. Hayward reports grants from the National Institute of Diabetes and Digestive and Kidney Diseases and the Veterans Affairs Health Services Research and Development Service during the conduct of the study. Dr. Pencina reports grants from PCORI (Tufts Subaward) during the conduct of the study; grants from Sanofi/Regeneron, Amgen, and Bristol-Myers Squibb outside the submitted work; and personal fees from Boehringer Ingelheim and Merck outside the submitted work. Dr. Ross reports personal fees from PCORI during the conduct of the study and grants from the U.S. Food and Drug Administration, Medtronic, Johnson & Johnson, the Centers for Medicare & Medicaid Services, Blue Cross Blue Shield Association, the Agency for Healthcare Research and Quality, the National Institutes of Health (National Heart, Lung, and Blood Institute), and Laura and John Arnold Foundation outside the submitted work. Dr. Varadhan reports personal fees from Tufts University during the conduct of the study. Dr. Vickers reports grants from the National Institutes of Health during the conduct of the study. Dr. Wong reports grants from PCORI during the conduct of the study. Dr. Steyerberg reports royalties from Springer for his book Clinical Prediction Models. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at http://www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3667.

Corresponding Author: David M. Kent, MD, MS, Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box 63, Boston, MA 02111; e-mail, dkent1@tuftsmedicalcenter.org.

Current Author Addresses: Drs. Kent, Paulus, Raman, and Selker: Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box 63, Boston, MA 02111.

Dr. van Klaveren: Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.

Dr. D'Agostino: Boston University Mathematics and Statistics Department, 111 Cummington Street, Boston, MA 02215.

Dr. Goodman: Stanford University School of Medicine, 150 Governor's Lane, Room T265, Stanford, CA 94305.

Dr. Hayward: VA Ann Arbor Health Services Research and Development, 2800 Plymouth Road, Building 14, G100-36, Ann Arbor, MI 48109.

Dr. Ioannidis: Stanford Prevention Research Center, 1265 Welch Road, Stanford, CA 94305.

Ms. Patrick-Lake: Evidation Health, 167 2nd Avenue, San Mateo, CA 94401.

Dr. Morton: Virginia Tech, North End Center Suite 4300, 300 Turner Street NW, Blacksburg, VA 24061.

Dr. Pencina: Duke Clinical Research Institute, 200 Trent Street, Durham, NC 27710.

Dr. Ross: Yale University School of Medicine, PO Box 208093, New Haven, CT 06520.

Dr. Varadhan: Johns Hopkins University, Division of Biostatistics and Bioinformatics, 550 North Broadway, Suite 1103-A, Baltimore, MD 21205.

Dr. Vickers: Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, 2nd Floor, New York, NY 10017.

Dr. Wong: Tufts Medical Center, 800 Washington Street #302, Boston, MA 02111.

Dr. Steyerberg: Erasmus University Medical Center, PO Box 2040, 3055 PC Rotterdam, the Netherlands.

Author Contributions: Conception and design: D.M. Kent, J.K. Paulus, R. Hayward, J.P.A. Ioannidis, J.S. Ross, A. Vickers, J.B. Wong, E.W. Steyerberg.

Analysis and interpretation of the data: D.M. Kent, J.K. Paulus, R. D'Agostino, R. Hayward, J.P.A. Ioannidis, J.B. Wong, E.W. Steyerberg.

Drafting of the article: D.M. Kent, J.K. Paulus, R. D'Agostino, A. Vickers, J.B. Wong.

Critical revision of the article for important intellectual content: D.M. Kent, J.K. Paulus, D. van Klaveren, R. D'Agostino, R. Hayward, J.P.A. Ioannidis, S. Morton, M. Pencina, G. Raman, J.S. Ross, R. Varadhan, A. Vickers, J.B. Wong, E.W. Steyerberg.

Final approval of the article: D.M. Kent, J.K. Paulus, D. van Klaveren, R. D'Agostino, S. Goodman, R. Hayward, J.P.A. Ioannidis, B. Patrick-Lake, S. Morton, M. Pencina, G. Raman, J.S. Ross, H.P. Selker, R. Varadhan, A. Vickers, J.B. Wong, E.W. Steyerberg.

Provision of study materials or patients: D.M. Kent, J.B. Wong.

Statistical expertise: D.M. Kent, D. van Klaveren, R. D'Agostino, R. Hayward, J.P.A. Ioannidis, S. Morton, R. Varadhan, A. Vickers, J.B. Wong, E.W. Steyerberg.

Obtaining of funding: D.M. Kent, J.K. Paulus, J.B. Wong.

Administrative, technical, or logistic support: D.M. Kent, J.K. Paulus, G. Raman, H.P. Selker, J.B. Wong.

Collection and assembly of data: D.M. Kent, J.K. Paulus, G. Raman, J.B. Wong.

Read the original:
The PATH Statement - Annals of Internal Medicine

This entry was posted on November 13, 2019 at 6:52 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |